Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rhythm Pharmaceuticals (RYTM) Return on Sales: 2021-2025

Historic Return on Sales for Rhythm Pharmaceuticals (RYTM) over the last 4 years, with Sep 2025 value amounting to -1.10%.

  • Rhythm Pharmaceuticals' Return on Sales rose 120.00% to -1.10% in Q3 2025 from the same period last year, while for Sep 2025 it was -1.10%, marking a year-over-year increase of 120.00%. This contributed to the annual value of -2.00% for FY2024, which is 38.00% up from last year.
  • Latest data reveals that Rhythm Pharmaceuticals reported Return on Sales of -1.10% as of Q3 2025, which was up 5.82% from -1.17% recorded in Q2 2025.
  • In the past 5 years, Rhythm Pharmaceuticals' Return on Sales ranged from a high of -1.10% in Q3 2025 and a low of -37.66% during Q1 2022.
  • In the last 3 years, Rhythm Pharmaceuticals' Return on Sales had a median value of -2.39% in 2023 and averaged -2.57%.
  • Data for Rhythm Pharmaceuticals' Return on Sales shows a peak YoY soared of 3,229bps (in 2023) over the last 5 years.
  • Over the past 5 years, Rhythm Pharmaceuticals' Return on Sales (Quarterly) stood at -24.60% in 2021, then soared by 1,696bps to -7.64% in 2022, then soared by 526bps to -2.39% in 2023, then soared by 38bps to -2.00% in 2024, then soared by 120bps to -1.10% in 2025.
  • Its Return on Sales was -1.10% in Q3 2025, compared to -1.17% in Q2 2025 and -1.23% in Q1 2025.